Home and telerehabilitation exercise program for people with Parkinson's disease
Official title: The Effects of Exercise Management in Parkinson's Disease
Run by Marmara University · NCT07302386 · Data updated 2026-11-12
This program will try to see if people with Parkinson's who manage their own exercise using telerehabilitation get similar or better walking, function, quality of life, and exercise adherence compared with a supervised exercise program.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 80 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Marmara University Academic / other |
| Locations | 1 site (Maltepe, Istanbul) |
| Status | Recruiting |
| Started | December 15, 2025 |
| Main results expected | November 7, 2026 |
| Study ends | December 2, 2026 |
| Registry record updated | March 31, 2026 |
| Trial ID | NCT07302386 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people with idiopathic Parkinson's disease, Hoehn & Yahr stage I–III, MoCA score ≥21, able to walk at least 100 meters, with at least a primary school education and access to the necessary technology for telerehabilitation.
✕Probably not a fit
Patients unlikely to benefit include those with DBS or other neurological disorders, cardiopulmonary or musculoskeletal conditions that affect gait or balance, significant sensory impairments, severe cognitive impairment (MoCA <21), or who lack the required technology.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial will enroll people with idiopathic Parkinson's disease (Hoehn & Yahr I–III) who meet cognitive and mobility criteria and have internet-capable devices. Participants will be assigned to a telerehabilitation arm where they self-manage exercise timing using remote support or to a supervised exercise program, with standardized exercise prescriptions for both groups. Investigators will collect demographic and clinical data, use the Montreal Cognitive Assessment (MoCA) to confirm cognitive eligibility, and measure outcomes including quality of life, walking speed, functional parameters, and adherence. The study focuses on whether home-based telerehabilitation can overcome barriers like transportation and time constraints while delivering comparable benefits to supervised therapy.
Why it matters
Potential benefit: If successful, this approach could give patients a flexible, lower-burden way to maintain exercise that improves mobility, daily function, and long-term adherence while reducing travel and costs.
How similar studies have gone: Previous telerehabilitation and home-exercise studies in Parkinson's have shown promising improvements in mobility and adherence, but direct head-to-head comparisons with supervised programs remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with Idiopathic Parkinson's Disease by a neurologist according to the UK Parkinson's Disease Association Brain Bank clinical diagnostic criteria * H\&Y Stage I-III * Montreal Cognitive Assessment Scale MoCA≥21 * Having the necessary technological devices to participate in telerehabilitation * Being able to walk 100 meters * Having at least a primary school diploma Exclusion Criteria: * Presence of a neurological disorder other than Parkinson's disease * Presence of any cardiopulmonary or musculoskeletal problem that affects gait and balance * Receiving Deep Brain Stimulation (DBS) treatment or having undergone DBS surgery in the past * Presence of vision or hearing problems
Where it's running
-
Marmara University
Maltepe, Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Gökçe Kartal
- Email: gokcekrtl2@gmail.com
- Phone: +905055624837
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Parkinson’s Risk in Gaucher Disease Type 1
This study tests how Parkinson’s risk relates to GBA1-related Gaucher disease in adults over 40, by collecting detailed clinical data and samples for future research.
-
Can the Ronnie Gardiner Method improve thinking and daily function in people with Parkinson’s
In this 10-week program, adults with Parkinson’s disease will try the Ronnie Gardiner Method to see if it helps thinking, talking, movement, balance, and quality of life.
-
Effects of excitatory and inhibitory LIFUS of GPi in Parkinson’s patients without DBS
This study tests two deep-brain focused ultrasound patterns on people with Parkinson’s to see if they change task performance and tremor, compared with a sham stimulation.
-
Capacitive-resistive radiofrequency therapy for people with Parkinson's disease
This study tests four TECAR therapy protocols on the legs to see which best reduces muscle stiffness and improves walking in people with Parkinson's disease.
-
TRB-001 safety and immune response in early Parkinson's disease
This early-phase study tests TRB-001 against placebo to see if it is safe and prompts an immune response in people with recently diagnosed Parkinson’s disease.
-
Bayesian optimization to tune DBS for better gait in Parkinson’s patients
This study tests whether using Bayesian optimization can quickly find DBS settings that lengthen step length in people with Parkinson's who already have DBS in place.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.